Clinical Trial Update: IVIG/Rituximab vs Rituximab in Kidney Transplant With de Novo Donor-specific Antibodies [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing IVIG/Rituximab versus Rituximab in kidney transplant patients with de novo donor-specific antibodies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplant

Drugs mentioned

• IVIG/Rituximab
• Rituximab (rituximab)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Renal Transplant | Phase 4 | Status: COMPLETED